Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml)

Slides:



Advertisements
Similar presentations
c-Myc expression in response to pre-TCR stimulation.
Advertisements

A B C MDA-MB-231 OHT: h FOXM1 PLK CDC25b ERα Tubulin
Analysis of CD151 and CD147 as potential prostate cancer biomarkers.
Molecular Therapy - Nucleic Acids
Proline supplementation during P5CS protein knockdown suppressed GCN2 activation. Proline supplementation during P5CS protein knockdown suppressed GCN2.
NM-3 induces p21 levels and down-regulation of Cdk2 activity.
Changes in mutation rate or protein abundance are not observed in HATs when comparing rho+ to rho0 cells. Changes in mutation rate or protein abundance.
Expression changes of specific epigenetic-controlled tumor-related genes by the prenatal/maternal BSp treatment. qRT-PCR and Western blot analysis were.
Lapatinib reduces IGF-I signaling in trastuzumab-resistant cells.
Knocking down Wnt3 increases the cells' response to trastuzumab and reduces cells' invasiveness. Knocking down Wnt3 increases the cells' response to trastuzumab.
Stability of SsbA (A) and GFP (B) proteins in UA159 and ΔclpX strains.
The p53 pathway is involved in the inhibition of cell proliferation observed in 15-LOX-1-overexpressing cells. The p53 pathway is involved in the inhibition.
A, IC50 dose–response curves of SYD985, T-DM1, and ADC isotype control in all USC cell lines tested in vitro (i.e., HER2 3+ cell lines, P =
Linearity of the relationships between spectral abundance factors observed when 30 and 120 μg protein were analyzed, as described in research design and.
BCL-3 regulates expression of stemness-associated Wnt targets.
The sesquiterpene lactone PN up-regulates MDM2 and p53 proteins.
The effects of the FASN blocker C75 on cell growth and survival (A, E, and F), on expression/phosphorylation of PI3K and MAPK signaling proteins and on.
A, IGFBP-3 knockdown via siRNA using real-time qRT-PCR analysis.
Immunohistochemical detection of 8-OHdG by use of the 1F7 monoclonal antibody in oligomer-treated PC3 prostate cancer cells. a, control untreated peripheral.
Effect of sustained suppression of HDAC2 in MKN-1 cells on in vitro tumorigenicity. Effect of sustained suppression of HDAC2 in MKN-1 cells on in vitro.
A, rate of proliferation of PC3 prostate cancer cells is greatly reduced by treatment with oligomers containing CpG motifs, as assessed by (a) soft agar.
Variation in dUTPase expression in cell lines.
A, ATP production by PC3 prostate cancer cells after treatment with oligonucleotide/Lipofectin complexes. a, ATP production by PC3 prostate cancer cells.
A, cytotoxicity induced on HER2 3+ USC (ARK-2), HER2 0/1+ USC (ARK-4), and ARK-2/ARK-4 cocultures with 1 μg/mL of SYD985, T-DM1, and ADC isotype control.
Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.
Subcutaneous tumor growth was significantly increased in Ogt-Tg/+ mice
Identification of NSC as a FADD-kinase inhibitor.
Effect of LY on phosphorylation of various MAP kinase substrates in HeLa cells in vitro. Effect of LY on phosphorylation of various MAP kinase.
Activation of CHOP and DR5 by DIM-C-pPhtBu.
BME treatment increases granzyme B expression in NK 3.3 cells.
Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells. Mcl-1 knockdown promotes cleavage of caspase-3 in nonadherent melanoma cells.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
Quercetin induces apoptosis in P39 xenografts.
Sensor siRNAs can be used in high-order combinations.
EGFR and cetuximab sensitivity of SCCUAT
Ki-67 expression is determined by the cell-cycle stage.
Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. Effect of other nucleoside analogues on p38 MAPK phosphorylation levels. A, MM.1S.
Western blot analysis of Wnt signaling genes.
VEGF expression in neoplastic and normal prostate tissue.
MiR-200c is a PI3K–AKT signaling pathway regulator in CRC
Expression of CRC stem cell markers and L1 in CRC cells.
ONC201 activates an ISR, decreases cyclin D1 expression, and causes an accumulation of cells in G1 in TNBC cells sensitive to the compounds' antiproliferative.
Effect of TLR-4 ligation with LPS on NF-κB activation in EOC cells: (A) MyD88+ and (B) MyD88− EOC cells were treated with 10 μg/mL LPS for 1, 2, and 4.
Active AR signaling in enzalutamide-resistant xenograft tumors.
Curcumin suppresses the expression of antiapoptotic proteins in multiple myeloma cells. Curcumin suppresses the expression of antiapoptotic proteins in.
HDACI treatment leads to down-regulation of AR and neuroendocrine transdifferentiation of LNCaP or LAPC4 cells. HDACI treatment leads to down-regulation.
Src expression in a panel of human TCC cell lines.
Expression pattern of TLR-4 and MyD88 in EOC cells.
Expression of Her2 and drug efflux proteins in parental and resistant cell models. Expression of Her2 and drug efflux proteins in parental and resistant.
Xenograft regrowth studies.
Flow cytometric analysis of ROS production in oligonucleotide-treated PC3 prostate cancer cells as demonstrated by the oxidation of H2DCF → DCF and HE.
Localization of oxidated thiols in A375 melanoma cells.
SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression. SBC-5 miR-335+, but not SBC-5 miR-29a+, exhibited reduced IGF-IR expression.
Changes in signal transduction pathway induced by gefitinib.
Characterization of DNA-PK and PARP-1 levels and activities in the cell lines studied. Characterization of DNA-PK and PARP-1 levels and activities in the.
Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors. Met is expressed in Her2-overexpressing cell lines and Her2 (+) breast tumors.
Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Enhanced expression of Cap43 gene by nickel in breast cancer cell lines. Expression.
CHL-induced apoptosis in HCT116 cells involves the activation of procaspase-8 and procaspase-6, with cleavage of nuclear lamins. CHL-induced apoptosis.
SAHA blocks IR-induced increase of RAD51 protein in MM cells.
Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3 S284 through MDM2. Cell-cycle regulatory proteins were controlled by O-GlcNAc at FOXO3.
Expression data from genes involved in regulation of transit through the cell cycle in response to treatment with E2 and OHT. A. Expression data from genes.
Induction of PARP cleavage (A) and activation of caspases (B) after treatment with a combination of TRAIL and cisplatin. Induction of PARP cleavage (A)
MYC expression is correlated with dasatinib sensitivity in cancer cell lines and in vivo. MYC expression is correlated with dasatinib sensitivity in cancer.
RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis in ovarian cancer cells. RA-9 induces G2–M cell-cycle arrest and caspase-mediated apoptosis.
Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105. Blockade of cell cycle at G2-M phase in Bel-7402 cells treated with IG-105.
LY elicits hyperphosphorylation of Akt.
Depletion of murine Dnmt proteins after 5-Aza-CdR treatment.
Effects of NMT siRNAs on MARCKS and c-Src.
I3C reduces the level of Cdc25A protein in breast cancer cells.
miR-181a knockdown inhibits VEGF and MMP1 secretion in vitro.
Presentation transcript:

Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml) treatment. Representative Western blot analyses of S-phase and other proteins from PC3 cell lysates obtained 3 days after oligomer (400 nm)/Lipofectin (15 μg/ml) treatment. Approximately 30–40 μg of protein samples were loaded in each lane. No change in the level of expression of pro-caspase 3 protein or in its cleavage to caspase 3 was observed after treatment with oligonucleotides. Compared with G4126, G3139 dramatically down-regulated the expression of several S-phase genes, including c-myb and PARP. However, no PARP cleavage products were observed. Levels of cdk2, cdk4, c-myc, α-tubulin, and cyclin D1 expression also remained essentially unaltered after 3 days. Jonathan C. Lai et al. Mol Cancer Ther 2003;2:1031-1043 ©2003 by American Association for Cancer Research